Last updated: September 2026
Mimosa Tenuiflora — commonly sold under its older synonym Mimosa Hostilis, and also known as Jurema Preta or Tepezcohuite — has a long history in Mexican and Brazilian folk medicine for skin repair. That traditional use has drawn growing interest from formulators looking for plant-derived actives in hair and scalp care. This guide summarizes what the peer-reviewed research actually shows, where the evidence is strong, where it’s still limited, and how to work with the ingredient responsibly in a formulation.
Why Formulators Are Looking at Mimosa Tenuiflora
The root and stem bark of M. tenuiflora is rich in condensed tannins, steroidal saponins, flavonoids (including sakuranetin and isosakuranetin), and polysaccharides such as arabinogalactans. Interest in the ingredient traces back to its documented use on burn victims in Mexico in the 1980s, after which researchers began investigating what in the bark was actually doing the work. Since then, several published studies have examined its effects on skin cells, wound closure, and inflammation — findings that formulators are now extending, with appropriate caution, into scalp and hair applications.
What the Research Actually Shows
It’s worth being precise here: most peer-reviewed research on M. tenuiflora has been conducted on skin, not hair, and formulators should be careful not to overstate what the data supports.
- Fibroblast activity. A study published in the Journal of Ethnopharmacology found that arabinogalactans isolated from M. tenuiflora bark significantly stimulated proliferation of dermal fibroblasts in vitro, with a comparatively minor effect on keratinocytes — offering a mechanistic explanation for the bark’s traditional use in wound healing.
- Clinical wound outcomes. A randomized, double-blind, placebo-controlled trial in patients with venous leg ulcers found that a hydrogel standardized to 1.8% tannin content from M. tenuiflora bark improved healing outcomes over 13 weeks compared with a tannin-free control.
- Anti-inflammatory and antinociceptive activity. Research published in PLOS ONE isolated flavones (including sakuranetin) from the ethanolic bark extract and demonstrated measurable anti-inflammatory and pain-reducing effects in animal models.
- Antimicrobial and tissue-engineering potential. Studies combining M. tenuiflora extract with chitosan films reported broad-spectrum antimicrobial activity and biocompatibility, supporting its exploration in wound-dressing and skin-regeneration applications.
Taken together, this body of work supports plausible mechanisms — astringency from tannins, fibroblast stimulation, antimicrobial activity, and anti-inflammatory flavonoids — that could reasonably translate to benefits for scalp condition and hair fiber integrity. However, formulators should note that dedicated clinical trials measuring hair growth, hair density, or hair breakage specifically (rather than skin healing) are limited in the current literature. Marketing copy should reflect that distinction rather than presenting skin-study findings as direct proof of hair-growth claims.
Potential Applications in Hair Care
Based on the mechanisms above, several formulation directions are reasonable to explore:
Shampoos and cleansers. The tannin and saponin content may support a gentle cleansing profile with astringent, root-tightening properties, while documented antimicrobial activity could support scalp-balancing claims when substantiated by in-house testing.
Conditioners and hair masks. The polysaccharide fraction (arabinogalactans) may contribute to film-forming and moisture-retention properties, making the ingredient a candidate for pairing with humectants like glycerin or emollients such as shea butter.
Scalp treatments and serums. Given the anti-inflammatory and fibroblast-stimulating data from skin studies, leave-in scalp serums are a logical extraction application — though claims around dandruff or irritation should be substantiated with product-specific testing rather than extrapolated wholesale from skin-ulcer research.
Leave-in and protective products. The flavonoid and antioxidant fraction may offer some protection against environmental oxidative stress on the hair fiber, consistent with the general antioxidant behavior of polyphenol-rich plant extracts.
Regulatory and Sourcing Considerations
Cosmetic chemists working with this ingredient should be aware of a few practical issues:
- Botanical naming. Regulatory filings and INCI listings should use the accepted botanical name Mimosa tenuiflora, with Mimosa hostilis noted as a synonym where relevant.
- Alkaloid content. The bark naturally contains trace amounts of the tryptamine alkaloid N,N-dimethyltryptamine (DMT). This does not affect topical cosmetic safety, but it does mean raw bark import and trade are restricted or controlled in some jurisdictions. Sourcing should go through suppliers who can document legal compliance and provide a certificate of analysis.
- Standardization. Because the clinical trial referenced above used an extract standardized to a specific tannin concentration, batch-to-batch consistency (tannin/saponin content) should be verified via supplier documentation and, ideally, in-house analytical testing.
- Substantiation. As with any botanical positioned around “natural” or “clean beauty” claims, efficacy statements — especially anything implying hair growth or medical benefit — should be backed by product-specific testing to stay within advertising and cosmetic-labeling guidelines in your target markets.
Best Practices for Formulation
- Source from verified, ethical suppliers who can provide documentation on harvesting practices, contaminant testing, and alkaloid compliance.
- Preserve potency by storing powdered bark or extract in airtight, light-protected containers, and confirm the finished formula’s pH is compatible with the extract’s stability range.
- Run stability and compatibility testing to check for interactions with preservative systems, surfactants, or other actives, and to confirm shelf-life performance.
- Pair claims with evidence. Where marketing claims go beyond what your own testing shows, qualify them (“traditionally used for,” “may help support”) rather than presenting them as established fact.
Frequently Asked Questions
Is Mimosa Tenuiflora the same as Mimosa Hostilis?
Yes. Mimosa hostilis is an older, still widely used common/trade name for the same species now classified botanically as Mimosa tenuiflora. Regulatory filings and INCI listings should reference Mimosa tenuiflora as the primary name.
Is there scientific evidence that Mimosa Tenuiflora grows hair?
Not directly. Published research shows it stimulates dermal fibroblast activity, has anti-inflammatory and antimicrobial properties, and supports wound healing in skin studies — mechanisms that are plausibly relevant to scalp health, but no clinical trials to date have measured hair growth or density as an endpoint. Claims should be framed as supported by related dermatological evidence, not proven hair-growth outcomes.
Is Mimosa Tenuiflora safe to use topically in cosmetic formulations?
Existing clinical and in vitro research on skin application (including a randomized controlled trial on venous leg ulcers) has not reported significant adverse effects at tested concentrations. As with any new botanical, formulators should run their own safety and compatibility testing, including patch testing, before commercial use.
Does Mimosa Tenuiflora bark contain DMT, and does that affect cosmetic use?
The bark contains trace amounts of the naturally occurring alkaloid N,N-dimethyltryptamine (DMT). This doesn’t present a topical safety issue in a finished cosmetic product, but it does mean raw bark import, export, and trade are restricted or controlled in some countries. Formulators should source only from suppliers who can document legal compliance.
What forms of Mimosa Tenuiflora are used in hair care formulations?
Most commonly, powdered bark or a standardized aqueous/ethanolic extract. Extracts standardized to a known tannin percentage (as used in the published clinical trial) offer more predictable, batch-consistent performance than unstandardized powder.
How should Mimosa Tenuiflora be stored to preserve potency?
In an airtight container, away from direct light and moisture, at a stable room temperature. Formulators should also confirm the finished product’s pH falls within a range compatible with the extract’s stability.
The Bottom Line
Mimosa tenuiflora has a genuinely interesting evidence base — mostly built on dermatological wound-healing research — that gives formulators a legitimate, mechanism-backed reason to explore it in scalp and hair products. The strongest science so far supports skin-repair and antimicrobial applications; hair-specific outcomes are a reasonable extrapolation rather than a proven claim. Formulators who source responsibly, standardize their extracts, and match their marketing language to the actual evidence will be best positioned to use this ingredient credibly.
Sources
- Zippel, J. et al. Arabinogalactans from Mimosa tenuiflora bark as active principles for wound-healing properties. Journal of Ethnopharmacology. PubMed
- Therapeutic effectiveness of a Mimosa tenuiflora cortex extract in venous leg ulceration treatment. Journal of Ethnopharmacology. ScienceDirect
- Antinociceptive and Anti-inflammatory Activities of the Ethanolic Extract, Fractions and Flavones Isolated from Mimosa tenuiflora. PLOS ONE. PMC
- Chitosan/Mimosa tenuiflora films as potential cellular patch for skin regeneration. International Journal of Biological Macromolecules. ScienceDirect
